|
Variables
|
HL N = 33
|
NHL N = 17
|
|---|
|
Age
(Mean ± SD)
|
10.5 ± 4.5
|
8.1 ± 4.6
|
|
Sex
| | |
|
Male: n = 32
|
18
|
14
|
|
Female: n = 18
|
15
|
3
|
|
M:F ratio
|
1:2:1
|
4:6:1
|
|
LFT
(Mean ± SD)
| | |
|
ALT (IU/L)
|
25.2 ± 11.7
|
29.2 ± 12.7
|
|
AST (IU/L)
|
21.2 ± 11.4
|
21.7 ± 9.9
|
|
T. Bil (mg/dL)
|
1.1 ± 0.3
|
1.0 ± 0.4
|
|
KFT
(Mean ± SD)
| | |
|
Creatinine (mg/dL)
|
0.9 ± 0.3
|
1.0 ± 0.3
|
|
CBC
(Mean ± SD)
| | |
|
Hb (g/dL)
|
10.6 ± 2.2
|
7.6 ± 3.0
|
|
TLC (×109/l)
|
5.3 ± 3.6
|
2.9 ± 4.6
|
|
Plt (×109/l)
|
134.9 ± 79.1
|
171.3 ± 208.4
|
|
ANC (×109/l)
|
1.8 ± 1.3
|
1.4 ± 2.3
|
|
Mono (×109/l)
|
1.5 ± 1.2
|
0.6 ± 1.0
|
|
LDH (Mean ± SD) (IU/L)
|
207.4 ± 214.2
|
443.7 ± 667.5
|
|
ESR 1
st
hr
(Mean ± SD)
|
40.5 ± 31.1
|
35.4 ± 24.5
|
|
ESR 2
nd
hr
(Mean ± SD)
|
73.5 ± 63.7
|
65.1 ± 45.9
|
|
Phase of therapy
| | |
|
Induction: n = 24
|
15
|
9
|
|
Post-induction: n = 23
|
16
|
7
|
|
Salvage: n = 3
|
2
|
1
|
|
Stage of disease
| | |
|
I+II (n = 25)
|
19
|
6
|
|
III+IV (n = 25)
|
14
|
11
|
- SD: Standard deviation, LFT: Liver function test, ALT: Alanin aminotransferase, AST: Aspartate aminotransferase, T. Bil: Total bilirubin, KFT: Kidney function test, CBC: Complete blood picture, Hb: Hemoglobin concentration, TLC: Total leukocytic count, Plt: Platelet count, ANC: Absolute neutrophilic count, Mono: monocyte, LDH: Lactate dehydrogenase, ESR1: Erythrocyte sedimentation rate 1st hour, ESR2: Erythrocyte sedimentation rate 2nd hour
